» Articles » PMID: 17627018

2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA Adduct Formation and Mutagenesis in DNA Repair-deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-acetyltransferase 2

Overview
Date 2007 Jul 14
PMID 17627018
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx) is one of the most potent and abundant mutagens in the western diet. Bioactivation includes N-hydroxylation catalyzed by cytochrome P450s followed by O-acetylation catalyzed by N-acetyltransferase 2 (NAT2). In humans, NAT2*4 allele is associated with rapid acetylator phenotype, whereas NAT2*5B allele is associated with slow acetylator phenotype. We hypothesized that rapid acetylator phenotype predisposes humans to DNA damage and mutagenesis from MeIQx. Nucleotide excision repair-deficient Chinese hamster ovary cells were constructed by stable transfection of human cytochrome P4501A1 (CYP1A1) and a single copy of either NAT2*4 (rapid acetylator) or NAT2*5B (slow acetylator) alleles. CYP1A1 and NAT2 catalytic activities were undetectable in untransfected Chinese hamster ovary cell lines. CYP1A1 activity did not differ significantly (P > 0.05) among the CYP1A1-transfected cell lines. Cells transfected with NAT2*4 had 20-fold significantly higher levels of sulfamethazine N-acetyltransferase (P = 0.0001) and 6-fold higher levels of N-hydroxy-MeIQx O-acetyltransferase (P = 0.0093) catalytic activity than cells transfected with NAT2*5B. Only cells transfected with both CYP1A1 and NAT2*4 showed concentration-dependent cytotoxicity and hypoxanthine phosphoribosyl transferase mutagenesis following MeIQx treatment. Deoxyguanosine-C8-MeIQx was the primary DNA adduct formed and levels were dose dependent in each cell line and in the following order: untransfected < transfected with CYP1A1 < transfected with CYP1A1 and NAT2*5B < transfected with CYP1A1 and NAT2*4. MeIQx DNA adduct levels were significantly higher (P < 0.001) in CYP1A1/NAT2*4 than CYP1A1/NAT2*5B cells at all concentrations of MeIQx tested. MeIQx-induced DNA adduct levels correlated very highly (r2 = 0.88) with MeIQx-induced mutants. These results strongly support extrahepatic activation of MeIQx by CYP1A1 and a robust effect of human NAT2 genetic polymorphism on MeIQx-induced DNA adducts and mutagenesis. The results provide laboratory-based support for epidemiologic studies reporting higher frequency of heterocyclic amine-related cancers in rapid NAT2 acetylators.

Citing Articles

Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes.

Walls K, Hong K, Hein D Toxicol Lett. 2023; 383:192-195.

PMID: 37423373 PMC: 10528954. DOI: 10.1016/j.toxlet.2023.07.002.


Acetyl coenzyme A kinetic studies on -acetylation of environmental carcinogens by human -acetyltransferase 1 and its variant.

Habil M, Doll M, Hein D Front Pharmacol. 2022; 13:931323.

PMID: 36386142 PMC: 9650386. DOI: 10.3389/fphar.2022.931323.


Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Bellamri M, Walmsley S, Turesky R Genes Environ. 2021; 43(1):29.

PMID: 34271992 PMC: 8284014. DOI: 10.1186/s41021-021-00200-7.


Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Rendic S, Guengerich F Arch Toxicol. 2021; 95(2):395-472.

PMID: 33459808 PMC: 7880545. DOI: 10.1007/s00204-020-02971-4.


Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.

Leggett C, Doll M, States J, Hein D Arch Toxicol. 2020; 95(1):311-319.

PMID: 33136180 PMC: 7855884. DOI: 10.1007/s00204-020-02901-4.


References
1.
Ohgaki H, Hasegawa H, Suenaga M, Sato S, Takayama S, Sugimura T . Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis. 1987; 8(5):665-8. DOI: 10.1093/carcin/8.5.665. View

2.
Turesky R . The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr Drug Metab. 2004; 5(2):169-80. DOI: 10.2174/1389200043489036. View

3.
Turesky R, Rossi S, Welti D, Lay Jr J, Kadlubar F . Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. Chem Res Toxicol. 1992; 5(4):479-90. DOI: 10.1021/tx00028a005. View

4.
States J, Quan T, Hines R, Novak R, Runge-Morris M . Expression of human cytochrome P450 1A1 in DNA repair deficient and proficient human fibroblasts stably transformed with an inducible expression vector. Carcinogenesis. 1993; 14(8):1643-9. DOI: 10.1093/carcin/14.8.1643. View

5.
Yanagawa Y, Sawada M, Deguchi T, Gonzalez F, Kamataki T . Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res. 1994; 54(13):3422-7. View